Biblical worldview. Conservative perspectives. All the links from across the web that Patriots need updated throughout the day in one spot.
In this Dallas Express article…
- The FDA is reportedly accelerating its use of artificial intelligence by expanding internal AI tools and rolling out a unified data platform intended to centralize agency information and improve decision-making.
- The initiative appears aimed at increasing operational efficiency, potentially speeding up regulatory reviews, internal analysis, and broader administrative workflows across the agency.
- Centralizing data under a single platform could give the FDA more powerful analytics capabilities, allowing AI systems to process larger datasets spanning approvals, safety monitoring, and compliance activities.
- Supporters will likely frame this as modernization—bringing a notoriously slow federal bureaucracy into the AI era and reducing costly inefficiencies.
- Critics, however, will immediately raise concerns about algorithmic opacity, data governance, and whether AI-driven bureaucratic decision-making could reduce transparency or accountability.
- Expanding AI inside a powerful regulatory agency also raises broader questions about cybersecurity, data privacy, and whether automated systems could eventually influence decisions affecting drugs, food, medical devices, or public health guidance.
- The move reflects a much larger trend across government agencies racing to integrate AI infrastructure before clear long-term guardrails are fully established.
Read the full story: https://dallasexpress.com/national/fda-expands-ai-tools-launches-unified-data-platform/
Biblical worldview. Conservative perspectives. All the links from across the web that Patriots need updated throughout the day in one spot.
